...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients
【24h】

Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients

机译:钙调神经磷酸酶抑制剂的晚期停用可预防肾移植受者进行性左心室舒张功能障碍

获取原文
获取原文并翻译 | 示例

摘要

Background: Calcineurin inhibitor (CNI)-based therapy is associated with adverse cardiovascular effects. We examined the effects of late CNI or mycophenolate mofetil (MMF) withdrawal on echocardiographic parameters. Methods: This study was conducted as a substudy of a randomized trial in stable renal transplant recipients who were on a triple CNI-based regimen with prednisone and MMF that evaluated late concentration-controlled withdrawal of CNI or MMF on renal function. A total of 108 patients (age, 52.3±11.5 years; 67% male; at a median of 2.0 years post-transplantation, (interquartile range 1.3-3.3 years); estimated glomerular filtration rate, 57±16 mL/min/1.73 m; 66% on cyclosporine and 34% on tacrolimus) entered the cardiovascular substudy examining echocardiographic parameters at baseline and 2 years after randomization. In all patients, traditional cardiovascular risk factors were treated according to predefined targets. Results: Late CNI withdrawal prevented progressive development of left ventricular (LV) diastolic dysfunction, as assessed by markers of LV diastolic function (mitral deceleration time and mitral annular e′ velocity). Conversely, in the MMF-withdrawal group, the left atrial volume index (an indicator of chronic LV diastolic dysfunction) was significantly increased at 2 years (from 24.1±6.7 to 27.0±7.0 mL/m, P<0.05). In addition, CNI withdrawal resulted in a higher proportion of patients achieving the predefined blood pressure targets (<130/85 mm Hg: 41.5% vs. 12.7%, P=0.001) at 2 years while requiring less antihypertensive drugs. Changes in the left atrial volume index were significantly associated with treatment arm (P=0.03) and changes in systolic (P=0.005) and diastolic (P=0.005) blood pressure. Conclusions: Late CNI withdrawal, from a triple-drug regimen in stable renal transplant recipients, prevented progressive deterioration of LV diastolic function and facilitated better blood pressure control.
机译:背景:基于钙调神经磷酸酶(CNI)的治疗与不良心血管效应相关。我们检查了晚期CNI或霉酚酸酯(MMF)对超声心动图参数的影响。方法:本研究作为一项随机试验的子研究,在稳定的肾移植受者中接受了基于泼尼松和MMF的三重基于CNI的方案,评估了CNI或MMF的晚期浓度控制戒断对肾功能的影响。共有108例患者(年龄52.3±11.5岁;男性67%;移植后中位2.0年(四分位间距1.3-3.3岁);估计的肾小球滤过率57±16 mL / min / 1.73 m ; 66%的环孢素和他克莫司的34%)进入心血管亚研究,在基线和随机分组后2年检查超声心动图参数。在所有患者中,传统心血管危险因素均按照预定目标进行治疗。结果:根据左心室舒张功能的指标(二尖瓣减速时间和二尖瓣环e'速度)评估,晚期CNI撤药可阻止左心室(LV)舒张功能障碍的进展。相反,MMF撤药组在2年时左心房容积指数(慢性左心室舒张功能障碍的指标)显着增加(从24.1±6.7升至27.0±7.0 mL / m,P <0.05)。此外,CNI撤离导致2年内有更高比例的患者达到预定的血压目标(<130/85 mm Hg:41.5%vs. 12.7%,P = 0.001),同时需要的降压药较少。左心房容积指数的变化与治疗组(P = 0.03)以及收缩压(P = 0.005)和舒张压(P = 0.005)显着相关。结论:在稳定的肾移植受者中,从三联疗法中晚期撤出CNI可以防止LV舒张功能的逐步恶化,并有助于更好地控制血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号